drugset / Trial / NCT07083011
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Non-randomizedParallel-groupSingle-blindDiagnostic
Summary
The purpose of this study is to assess the performance of 68Ga- FAPI PET in heart failure with preserved ejection fraction (HFpEF)
Timeline
- Start
- 2025-11-01
- Primary completion
- 2027-07
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAPI GA-68 | Diagnostic / imaging agent | — | — |